0000899243-20-029553.txt : 20201028
0000899243-20-029553.hdr.sgml : 20201028
20201028182914
ACCESSION NUMBER: 0000899243-20-029553
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201026
FILED AS OF DATE: 20201028
DATE AS OF CHANGE: 20201028
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hager Alicia J.
CENTRAL INDEX KEY: 0001553354
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39370
FILM NUMBER: 201269944
MAIL ADDRESS:
STREET 1: C/O ONCOMED PHARMACEUTICALS, INC.
STREET 2: 800 CHESAPEAKE DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nkarta, Inc.
CENTRAL INDEX KEY: 0001787400
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 474515206
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6000 SHORELINE COURT
STREET 2: SUITE 102
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-215-0385
MAIL ADDRESS:
STREET 1: 6000 SHORELINE COURT
STREET 2: SUITE 102
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-10-26
0
0001787400
Nkarta, Inc.
NKTX
0001553354
Hager Alicia J.
C/O NKARTA, INC.
6000 SHORELINE COURT, SUITE 102
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Chief Legal Officer
Stock Option (right to buy)
31.11
2020-10-26
4
A
0
150000
0.00
A
2030-10-25
Common Stock
150000
150000
D
The option is scheduled to vest and become exercisable as to 25% of the shares subject to the grant on October 26, 2021. The remaining portion of the option is scheduled to vest and become exercisable in 36 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following October 26, 2021.
/s/ Alicia J. Hager
2020-10-28